Karen E. Wood

Learn More
PURPOSE Lenvatinib is an oral multi-targeted tyrosine kinase inhibitor of VEGFR1-3, FGFR1-4, PDGFRβ, RET, and KIT. Everolimus is an oral mammalian target of rapamycin inhibitor approved for advanced renal cell carcinoma (RCC). This phase 1b study assessed safety, maximum tolerated dose (MTD), and preliminary antitumor activity of lenvatinib plus everolimus(More)
Sympatric speciation is the emergence of new species from a single ancestral species while inhabiting the same geographic region. This process presents an interesting problem for theoretical studies of evolution. One mechanism by which sympatric speciation might occur is periodic or quasiperiodic fluctuations in the abundance of the resources. In this paper(More)
  • 1